Prospect: information for the user
Celecoxib Vir-Pharma 200 mg hard capsules EFG
Read this prospect carefully before starting to take this medication, as it contains important information for you.
Celecoxib belongs to a class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs), and specifically to the subgroup known as selective cyclooxygenase-2 (COX-2) inhibitors. The body produces prostaglandins that can cause pain and inflammation. In conditions such as rheumatoid arthritis or osteoarthritis, the body produces them in greater quantities. Celecoxib acts by reducing the production of prostaglandins, thereby reducing pain and inflammation.
Celecoxib Vir-Pharma is indicated in adults to alleviate the symptoms ofrheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.
The medication will start to take effect a few hours after taking the first dose, but you may not experience a complete effect until several days have passed.
Do not take Celecoxib Vir-Pharma
Inform your doctor if any of the following circumstances affect you, as patients with these conditions should not take Celecoxib Vir-Pharma:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Celecoxib Vir-Pharma:
anticoagulant analogs of warfarin or new oral anticoagulants, e.g., apixaban)
Like othernonsteroidal anti-inflammatory drugs(e.g., ibuprofen or diclofenac), this medication may increase your blood pressure, so your doctor may perform regular checks.
Some cases ofsevere liver damagehave been reported with celecoxib, including severe liver inflammation, liver damage, and liver failure (some with fatal outcome or requiring liver transplant).Most of the severe liver damage cases occurred in the first month of treatment.
Celecoxib Vir-Pharma may make it difficult to becomepregnant. You should inform your doctor if you plan to become pregnant or if you have difficulty becoming pregnant (see Pregnancy and breastfeeding).
Use of Celecoxib Vir-Pharma with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication, such as:
Celecoxib Vir-Pharma can be taken with low doses ofacetylsalicylic acid(75 mg daily or less). Consult your doctor before taking both medications together.
Pregnancy and breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Celecoxib Vir-pharma should not be used by pregnant women or women who may become pregnant (i.e., women of childbearing age who do not use an adequate contraceptive method) during treatment. If you become pregnant during treatment with Celecoxib Vir-Pharma, discontinue treatment and contact your doctor for alternative treatment.
Breastfeeding
Celecoxib Vir-Pharma should not be used during breastfeeding.
Fertility
NSAIDs, including Celecoxib Vir-Pharma, may make it difficult to become pregnant. You should inform your doctor if you plan to become pregnant or if you are having difficulty becoming pregnant.
Driving and operating machinery
You should know how you react to Celecoxib Vir-Pharma before driving or operating machinery. If you feel dizzy or drowsy after taking Celecoxib Vir-Pharma, do not drive or operate machinery until these effects pass.
Celecoxib Vir-Pharma contains lactose
This medication contains lactose (a type of sugar). If your doctor has told you that you have a lactose intolerance, consult with them before taking this medication.
Celecoxib Vir-Pharma contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per capsule; that is, it is essentially “sodium-free”.
Your doctor will indicate the dose you should take. Since the risk of adverse effects associated with heart problems may increase with the dose and duration of treatment, it is essential to use the lowest dose that controls your pain and do not take Celecoxib Vir-Pharma for longer than necessary to control symptoms.
Administration form:
Celecoxib Vir-Pharma must be administered orally.The capsules can be taken at any time of the day, with or without food. However, try to take each dose of Celecoxib Vir-Pharma at the same time every day.
If you have difficulty swallowing the capsules: you can spread the entire content of the capsule on a teaspoon of some semi-solid food (such as apple sauce, rice, yogurt, or mashed banana at room temperature) and swallow it immediately with a glass of approximately 240 ml of water.
To open the capsule, hold it in a vertical position to keep the granules at the bottom; then, press the top and turn it to extract it, being careful not to spill the content.Do not chew or crush the granules.
Contact your doctor if, after two weeks of starting treatment, you do not experience an improvement.
The recommended dose is:
The recommended dosefor the treatment of arthritisis 200 mg per day, if necessary, your doctor may increase it up to a maximum of 400 mg.
The usual dose is:
The recommended dosefor the treatment of rheumatoid arthritisis 200 mg per day, if necessary, your doctor may increase it up to a maximum of 400 mg
-The recommended initial dose of 200 mg (administered in two doses of 100 mg per day) is not possible with this medication. Please consult your doctor.
The recommended dosefor the treatment of ankylosing spondylitisis 200 mg per day, if necessary, your doctor may increase it up to a maximum of 400 mg.
The usual dose is:
Patients with kidney or liver problems:make sure your doctor knows if you have liver or kidney problems since you may need a lower dose.
Patients over 65 years old, especially those weighing less than 50 kg: your doctor may want to monitor you more closely if you are over 65 years old and especially if you weigh less than 50 kg.
You should not take more than 400 mg per day
Use in children
Celecoxib Vir-Pharma is only for adults, it is not indicated for children.
If you take more Celecoxib Vir-Pharma than you should
You should not take more capsules than indicated by your doctor. If you take more Celecoxib Vir-Pharma than you have been told, consult your doctor, pharmacist, or hospital immediately and bring the medication with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service (phone 91 562 04 20), indicating the medication and the amount taken.
If you forgot to take Celecoxib Vir-Pharma
If you forgot to take a capsule, take it as soon as you remember. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Celecoxib Vir-Pharma
Stopping treatment with Celecoxib Vir-Pharmamay cause a worsening of symptoms. Do not stop taking this medication unless your doctor tells you to. Your doctor will indicate that you reduce the dose over a few days before stopping treatment completely.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may cause side effects, although not everyone will experience them.
The side effects listed below were observed in patients with arthritis who took Celecoxib. The side effects marked with an asterisk (*) occurred in patients taking Celecoxib for the prevention of colon polyps and have been classified according to the highest frequency of occurrence. The patients included in these studies took Celecoxib at high doses and for a prolonged period of time.
If you experience any of the following side effects, discontinue treatment with Celecoxib Vir-Pharma and inform your doctor immediately:
If you have:
Very common (may affect more than 1 in 10 patients)
Common (may affect up to 1 in 10 patients)
Uncommon (may affect up to 1 in 100 patients)
Rare (may affect up to 1 in 1,000 patients)
Muy rare: (may affect up to 1 in 10,000 patients):
Frequency not known (cannot be estimated from available data):
-Decreased fertility in women, which is normally reversible if medication is discontinued.
Side effects reported in clinical trials in which celecoxib was administered at a dose of 400 mg per day for a period of up to 3 years in patients with non-arthritis-related diseases or other arthritic conditions were:
Common (may affect up to 1 in 10 patients)
Uncommon (may affect up to 1 in 100 patients)
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:http://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister pack and on the packaging, after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Celecoxib Vir-Pharma
The active ingredient is celecoxib.
Each hard capsule contains 200 mg of celecoxib.
The other components (excipients) are: the granule contains lactose monohydrate, povidone, croscarmelose sodium, laurilsulfate of sodium, magnesium stearate (E572) (The capsule coating contains gelatin (E441), titanium dioxide (E171), iron oxide yellow (E172). The printing ink contains shellac lacquer (E904), propylene glycol (E1520) and iron oxide yellow (E-172).
Appearance of the product and content of the container
Hard, opaque, white capsules. The body contains a yellow band with the text “C9OX-200” in white.
Celecoxib Vir-Pharma may be presented in containers of 1, 10, 20, 30, 40, 50, 60 or 100 hard capsules.
Only some container sizes may be commercially available.
Marketing Authorization Holder
Industria Química y Farmacéutica VIR, S.A.
C/ Laguna 66-70, Polígono Industrial URTINSA II
28923 Alcorcón (Madrid)
Spain
Responsible for manufacturing
Synthon BV
Microweg 22
6545 CM, Nijmegen
Netherlands
or
Synthon Hispania S.L
Castelló, 1
Polígono Las Salinas
08830 Sant Boi de Llobregat
Spain
or
Industria Química y Farmacéutica VIR, S.A.
C/ Laguna 66-70, Polígono Industrial URTINSA II
28923 Alcorcón (Madrid)
Spain
or
G.L. Pharma GmbH
Schlossplatz 1,
8502 Lannach,
Austria
This medicine is authorized in the member states of the European Economic Area with the following names:
NetherlandsLicebril 200 mg, capsules, hard
Spain Celecoxib Vir-Pharma 200 mg hard capsules EFG
Last review date of this leaflet: July 2023
Detailed and updated information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.